SB 1727
7 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Lilly USA | Lobbied on it | Lilly USA named SB 1727 in 4 lobbying reports. | 4 reports |
| Pharmacia | Lobbied on it | Pharmacia named SB 1727 in 4 lobbying reports. | 4 reports |
| Wyeth | Lobbied on it | Wyeth named SB 1727 in 3 lobbying reports. | 3 reports |
| GSK | Lobbied on it | GSK named SB 1727 in 2 lobbying reports. | 2 reports |
| AARP | Lobbied on it | AARP named SB 1727 in 1 lobbying report. | 1 report |
| Allergan, Inc. and Its Affiliates | Lobbied on it | Allergan, Inc. and Its Affiliates named SB 1727 in 1 lobbying report. | 1 report |
| University of California: Pharmaceutical Evaluation Commission. | Source records | SB 1727 has an explicit source reference to University of California: Pharmaceutical Evaluation Commission.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…